Tenboron

About:

Tenboron is the developer of a boron neutron capture therapy intended to treat locally invasive malignant tumors.

Top Investors: Innovestor

Description:

Tenboron is biochemically targeted radiation therapy. They offer services for boron neutron capture therapy designed to treat locally invasive malignant tumors.

Total Funding Amount:

4.5M EUR

Headquarters Location:

Helsinki, Southern Finland, Finland

Founded Date:

2010-01-01

Founders:

Erkki Tenhunen

Number of Employees:

1-10

Last Funding Date:

2019-05-03

IPO Status:

Private

Industries: